At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
4 raab, michael Jun 11, 2009 19.5 KB View HTML View PDF View XLS  
4 neff, p sherrill Jun 11, 2009 19.7 KB View HTML View PDF View XLS  
4 hayden, donald j jr Jun 11, 2009 19.6 KB View HTML View PDF View XLS  
4 barkas, alexander e Jun 11, 2009 19.8 KB View HTML View PDF View XLS  
4 barer, sol j Jun 11, 2009 19.6 KB View HTML View PDF View XLS  
4 dentzer, james e Jun 1, 2009 19.7 KB View HTML View PDF View XLS  
EFFECT effectiveness order May 27, 2009 0.0 KB View HTML  
S-3/A registration statement May 26, 2009 235.0 KB View HTML View PDF View XLS  
S-3/A registration statement May 19, 2009 207.1 KB View HTML View PDF View XLS  
10-Q quarterly report May 8, 2009 277.9 KB View HTML View PDF View XLS  
8-K current report May 7, 2009 76.7 KB View HTML View PDF View XLS  
4 dentzer, james e May 4, 2009 19.7 KB View HTML View PDF View XLS  
DEF 14A definitive proxy statement Apr 24, 2009 591.0 KB View HTML View PDF View XLS  
S-3 registration statement Apr 3, 2009 562.2 KB View HTML View PDF View XLS  
4 dentzer, james e Apr 2, 2009 19.7 KB View HTML View PDF View XLS  
4 palling, david Apr 1, 2009 19.2 KB View HTML View PDF View XLS  
4 palling, david Mar 26, 2009 19.2 KB View HTML View PDF View XLS  
4 palling, david Mar 25, 2009 19.2 KB View HTML View PDF View XLS  
4 palling, david Mar 20, 2009 19.2 KB View HTML View PDF View XLS  
4 crowley, john f Mar 13, 2009 20.6 KB View HTML View PDF View XLS  
Showing 561-580 of 937 Page: 1 ... 25 26 27 28 29 30 31 32 33 ... 47  Previous 20 | Next 20

Copyright © 2015 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy